BioWorld

March 26, 2004

Haseltine To Retire As HGS Refocuses, Cuts Employees

In an ever-changing industry, sometimes a biotech company must sacrifice a valuable asset - its people - for the good of the company. Take a bow, Dr. William Haseltine. (BioWorld Today) Read More

Gearing For Estorra Launch, Sepracor Ends Xopenex Deal

NeoGenesis, AstraZeneca Join For Small-Molecule Discovery

Point Therapeutics Privately Raising $13.5M For PT-100

Other News To Note

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...